Treatment algorithm for chronic hepatitis B in HIV-infected patients.

[1]  A. Mocroft,et al.  Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.

[2]  J. Sasadeusz,et al.  Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  B. McMahon,et al.  [AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]. , 2004, Romanian journal of gastroenterology.

[4]  D. Cooper,et al.  Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus. , 2004, The Journal of infectious diseases.

[5]  B. McMahon,et al.  Chronic hepatitis B: Update of recommendations , 2004, Hepatology.

[6]  Y. Benhamou.  Antiretroviral therapy and HIV/hepatitis B virus coinfection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  E. Schiff,et al.  A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  A. Blei.  The impact of Hepatology , 2004, Hepatology.

[9]  M. Brook,et al.  BHIVA Guidelines: coinfection with HIV and Chronic hepatitis B virus , 2003, HIV medicine.

[10]  C. Katlama,et al.  1155 Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients , 2003 .

[11]  E. Jury.  EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). , 2003 .

[12]  P. Marcellin,et al.  Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. , 2002, Gastroenterology.

[13]  A. Lok,et al.  Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection , 2002, Hepatology.

[14]  J. Phair,et al.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.

[15]  G. Papatheodoridis,et al.  Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance. , 2002 .

[16]  V. Calvez,et al.  Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study , 2001, The Lancet.

[17]  Nicholson,et al.  Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L‐FMAU, DAPD, penciclovir and lobucavir , 2000, Journal of viral hepatitis.

[18]  S. Kaur,et al.  Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy. , 2000, The American journal of medicine.

[19]  C. Katlama,et al.  Long‐term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus–infected patients , 1999, Hepatology.

[20]  E. Jury.  EASL International Consensus Conference on Hepatitis C , 1999, Journal of hepatology.

[21]  D. Cooper,et al.  Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee. , 1999, The Journal of infectious diseases.

[22]  M. Loriot,et al.  Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men , 1999, Hepatology.

[23]  D. Cooper,et al.  Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor , 1997, The Lancet.

[24]  R. Tubiana,et al.  Effects of Lamivudine on Replication of Hepatitis B Virus in HIV-Infected Men , 1996, Annals of Internal Medicine.

[25]  F. Carnot,et al.  Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients. , 1996, Gastroenterologie clinique et biologique.

[26]  A. Venn,et al.  Breast and ovarian cancer incidence after infertility and in vitro fertilisation , 1995, The Lancet.

[27]  C. Naylor,et al.  Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population. , 1995, Gastroenterology.

[28]  H. Thomas,et al.  Which patients with chronic hepatitis B virus infection will respond to α‐interferon therapy? A statistical analysis of predictive factors , 1989, Hepatology.

[29]  J. Harris,et al.  Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV‐III antibodies to recombinant α‐interferon , 1987, Hepatology.